Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.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?oc=5" target="_blank">FDA approves breakthrough drug to treat advanced pancreatic cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">ABC News - Breaking News, Latest News and Videos</font>
Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
Bank of America fined $1.2 billion over money-laundering violations
LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker
Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBXVTEyUmZaMXRsRDdaclU0M01vSjVlcTIweWNpcDdoc3Z5YUJGa015UXNIRlBZcGx1SEVITzAtZlhsWGNBcl81WDZwWDljd291VWg5Tkg4S19jNGNFRm1lbzJ6THQtTVdZelVN?oc=5" target="_blank">FDA Approves RASONQUE™ (daraxonrasib)</a>&nbsp;&nbsp;<font color="#6f6f6f">Pancreatic Cancer Action Network</font>
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOeHNJNW9TR0tGeFhxUnVTQWJ0ZkNibFlZU21kLWZXSmk5QmkzQllOVXh0blFjaEZfalJJazNPV3QybWpKS0lMMUR5bzVMSUl5OXhmWXJ0Z1laeERrekwxem00RVQ3MkI4NXVIQjVoOWRwZXM1bmRsTzMxR05PQl9ZNlkwZDlyaTVuNWVpTw?oc=5" target="_blank">Daraxonrasib for Pancreatic Cancer: What to Know</a>&nbsp;&nbsp;<font color="#6f6f6f">Mass General Brigham</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNUWVYQ2hvX1NJZTlscnVXMlE0OWRieEdIeUFKQS11bWJKU0txN0Y0b1hsLXVodmxXOEFjbnZMckNOYlJNSEtIc0lLWWNmVUdrV21CdGNCZ2diZ0R5OHVDTlEzWmhYSXJvWFhETktoc1pzMVlGUUdBRVFIMmpsZko2NW1Sd0FoU1VoMUJoYWNnbUVFQjRTRnFibktURmFhZk5UN2NVV3VybWlYcW5SQVRTc3BpVm4?oc=5" target="_blank">Daraxonrasib Approval Signals a New Era for RAS-Targeted Therapy in Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRDVtNGlYdktlSnJEMWZWdmFGX21NUFBpODZ4aUMtR2tUY0JBaXNENlVzNDBpQThmc0JLMFdMVS1ucmExbUVQV0hnYnhoeUtHMmp1VWdwR2pGN2wzelRGVGwyNnpEM3NteURwNDVzSGozaHFBelRPWENYV0lVeUdMQ05fSU9zUVBi?oc=5" target="_blank">FDA Approval Opens New Chapter in Pancreatic Cancer Treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">University of Miami</font>
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPTzBjSUV6QnZwVk11enBrTTl3VG14U0FNbnhOMWgtMUh0ejVYWVV1cFFjN3NjNTVfazZkZF9KSTZxcW9pZ1c1czJHcFFVMTRRU3RSY0FjQjBrY3kxbmtSei0tNlJENGt1ZzN0ZXVVcTdXbDBuNnJlSEN3WTRYanZxQ1FOTFB1alYyXzR6Y2xUUktNNmlPdEV5bWx5Rlp5NVZoQkdqUTN0NWxfZE5JcnUydVh3?oc=5" target="_blank">FDA Approves Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRldpVTdpQVFYOHlMSFJfMzZidHhCMlQyay1NaTl2emctQnl5Rk1pVkNvbTdTU0hnUzZDRHlDMWhMYVFBdnNhSkZmMTBabGg0OXAxVnV5M3ZjcU5DNUd1U1pYTmdrRExmRWx0bU1NZXlTam02alpfcW00UzJ2VEc2aDRIV2lyQ3JLckJsRFZLVXU5eTNOblhMd29wR254eDZiM1AxSEVHU2I?oc=5" target="_blank">FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQVW44aHFtT0xweVk4WjItWElHNnA4RU1EbFBUUmZhTGEyakJFRGtpdVlLQmprQVFzeTNlZ2hURzFMV2ZNZjkzd25PRGk3MWdLdXhxaXRWRDdoM2VLTS1VWm1FQjRpSDRPQ2NuM2dkRklaQnY5N1RKQTZtNjF2Y0ZxVXE1T0E4bHZoamZuSmc3dWxhcWVDMlJQMUxoOWZMVXNrUFQ1QXBB?oc=5" target="_blank">FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know</a>&nbsp;&nbsp;<font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNcDFUdlNabS1QTHFtUXBVNTVmczg5dmFGYVMzSlViVFRWRG1sTzZ1YWg4RnFyZndPZVBlUDhLZ1NMbHZSSTNGUmFmSmpmNVlhc1V0ZXhVbGdrWVVVOUY2dTFkU1VLMjNpN1lPbjNsN3BQcHVLczhaTDVsUnBfQnd5b21nYWxjZlMxdkc0SFdWVU0?oc=5" target="_blank">F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The New York Times</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPQWs2S1JYVzh5ZktJUE84Mkk5ZDlaUGRWd1pWNFdCNlRsZDdNeEhNQ2JwTlZBaWZoR3dJTVlscDVsbHZSUjhfZmFTZFNvelE2dm03WnRSajdEb3lnS0tmdkxGU2dQU2RoM3YwSFpBRjdocXd6MWVTb1l3ZWpMZzJTNnZ6RlQxd1QyZVZQeTl6Y2ZwTlF3b3FuNDBURnFoSk9ZQTRKdw?oc=5" target="_blank">FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology Nursing News</font>
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPekVHc3BmaWI0R3BaNk55ckxTMW8tMThWUG55MFBwM1pFQTRJVG5KN1BmYWpjdGtyRkwwZzU4RnFZWlJ0bzNLVVBUQWVLQlZTZXZMMkpwNHdIb25HUEtxZU8zQWFLOGcxWnM3M2ZyLWxrajFHRzFGOUxUZW9naThlTDRGUXRHeXJPcm96NEtvbTRLLTdYWkUzYVVMR2hMN1FDRHVqTjgwV0pzVnE3eGtBWGFmYmNkNHhuYjBPVU9XMGRDVzNDTlY3NzBFNzhXV2pfVTlnUWFpdWRkTlFGbFh5Yw?oc=5" target="_blank">FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival</a>&nbsp;&nbsp;<font color="#6f6f6f">The Conversation</font>
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNQnpqdUJBTnJwcXQ3NHBkZGZrbVJad3E2Z0tJNWgtVGoxaXB1RjF6RVBwWk8zTnh0Y05DSGx0Unk1Z282Y0JyLXdFQkp3cW1jTHd0YzdTOHRQLVpIQ3FJV1VVRzhENEhRV0YxMUMwcmRjaFFCVks5ZnFCeU4tX0dQMFd0ME5wX21mWU5McEstUDIwR25wX2c?oc=5" target="_blank">FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcFExajk5N25lWUNlVXhybVdrWGNWTEVfOGlSVk14WVY0dklnVFVzWWtHeWUxVXlJRjZYVzJNN0s2eWF3eDVhRHRlc0ZKd1AwNllTOGR6N2NaLXR0dlNOS1NOLVlxM2MxOGR4anVJSGlwNk9EVWF0TU00MkZQZ0RlQkNXWjdQbVV4MWwyVGt3Vm81QjQ0QzRWYVJrYWdrcm9YRkdITEwtQTR2NjA?oc=5" target="_blank">FDA Approves RAS Inhibitor Daraxonrasib for Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQSDYyMnVEWnpjZFNYbVE4Mno3bGJyYlNoZWlaNUgyQnNGNnRrV0pnWXI0Tl9Ndm41dDNDYlZ2M1loc3owT1FfZU4wX1FqSThNaTJGZ3NQRzltMXhpenRMR0pQRnhabG5PYVRqc2RKaWdqQUJiekN1dVo3ZnZJczBSMkJQd1Bkb0k0YXowN0E3b3hNLVRwZmpvZGxSXy1IZll0MWc?oc=5" target="_blank">Daraxorasib FDA Approval: A New Hope for Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology News Central</font>
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPX0ZRQVdCUXJnakhLSUxPVnVIT1NFWkl6TENOTVZXYlY1RHlCYkloSHRoY1piT29JR1lNZklQTVlaRHFsNzVlU01jUGltVHNvTXlVZm5BdmctdXRlVTNwLTFKTmdmYVZZUm9EbVBwSlNLTlhwRmxHZmxUemZZN3VyRUxxOHJWLVF1QlZOTXVXb2J3SWFkMF9JbFdWUExsZ3dMVmVjT1QzQ0FGZE9GZVNzTmpaWXlCQ1p4Tkg0c19rNnBsaG50QUp6eW1MZjdPRXI4cDRTSHdmYWk1NE1zVWk1cGxWa1FCNjZ5c0lWNTd6Rzk?oc=5" target="_blank">FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber</a>&nbsp;&nbsp;<font color="#6f6f6f">News-Medical</font>
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQMmcxNXRTU2s3bVhOc2psejVVTHpEb05TcEdmMG1wOUNaRHRYWk5XNHJBOGN5U0JQNXREU1NmU1Rza3ZaUjh6a3hiLXlubDF4UUY1ZTRZQ1RqMnFQWFM3a2lBUEZlRk41dUpPZm5PWF9nTVVXWmlBcDRxeHI0eEZkMUtzV3d2aDFzNTN2UWY3YmxQbU9tVk1nRjR0dEpkY19tWmpHYjFBUXJsdl83?oc=5" target="_blank">FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOOXpDRVhpVi1IWTF4U3NTdGU2dkJVZndoaEppT2RhWGEtcnk0M3lXdmZGSUg3eFpzeFZYWkZaVjZNVG1JWU5EQUJWVkhab242bUZGRHpFNEFGajdjWTZnZDBDM0xlaUpJdVNaVS1ZdmFpSDNnZy1PM0tOS0RxUWVxU2NSb0lQR2FGdFNsM2dCTTdManc4MVd2T3JhZEtmdVdVNkpqdg?oc=5" target="_blank">FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNLVZYYndRbGI5aEdMeTdrREw4OGpWR3g0dFh2dEt5ZHFuam1zQi1uUC1jRzBFamNad1daMUw5NDhZQU5DLW1SXy1FYVliTVEwTW1Kd1VXWFhJbm1IdE1XQUZDTGlWYzh0OVNvQWUxUTk1NGNGWm0zTE1sX0FqZlZRUWs5N2RDaWI5OGhnOGE5aWlxUjQ2WXFpLURKTEVxSjdO?oc=5" target="_blank">FDA Approval of Daraxonrasib Marks Turning Point in Pancreatic Cancer Care</a>&nbsp;&nbsp;<font color="#6f6f6f">Bioengineer.org</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOempjZ25FT08wSGpHc2hXTVZxSHRHN0tRM19kcHh4Q1U3TTBrMDRuOE1teFY5MFA2bmIxdk95MldRX2NQOGVZazVWcmFmN050WjlrQTkzazlZYWhmRmhOSzRMdXAtYTNtYjZNN2syeGdEV2lWeFFnNDBacnFZWmlKOUktcW9oOUtMTmZOaHhid1liOTFnbFJuYjRnbnl6cHFU?oc=5" target="_blank">New Pancreatic Cancer Drug Daraxonrasib Approved by FDA: What to Know</a>&nbsp;&nbsp;<font color="#6f6f6f">US News Health</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOZk5EbXc4bTZ2b2VJRlRKLW5UZVVRbmJBZTdQZllqYi0tREtXX0hjWFBUZHBCeXVvNWVqdXp3TzAwckJtZjlIa2poNExhcnozOVd0Vm9QcHlUSl8xMmNxVXFzTGx6b19ETEh2ZjdRRTU4YVJPWmVNWFlqR1BBQTNqTnF0NUVIR05ISlkxQi02UWp2TXUxZ0t5SHVQODRlTG1JSVdNVw?oc=5" target="_blank">FDA Approves Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPamduaU5uWklzcUp5WHB2eXVnR1JweTFjYnEtZUpxUTVqNmRvVTJrN3ItYzEyZEY2QWJoS0JpeWlYUlFXQnlJOWJNeFRhWmxMUVROZE5Bbm1POXB5THJDLXlFUkdqR2hHb1N2RnlKcmgzeU9yekxyRHk4dFo2eEQybW9jZTJjRnVEMzN5SnZMWEYxTmxwaGQ1YjNQM3otVk5XSlpna3hTX2Z3cEE?oc=5" target="_blank">Business Watch: Solstice, Element cancel deal; FDA approves daraxonrasib for pancreatic cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Chemical & Engineering News</font>
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeGxjU2NlQUY4ZU9vcmg0RlFEeWJFaWwtdmZHZmdTbmlkSGJfVWNJcVpUMi1zbGFDWC1QQ1Y5ckUwS1F1MXZyMkdOTWRIdngxSW92Y3pFU01jQ2lMQUVPNVRzRHdibVo2TUZ5VTBxWE1KX0J4UV9LbmE2eFJlMW85M0NBMnJqWDdZMjVvSHppX29RdGtRaGhfWE5pdGo4ZElTZFJha0lLamtFMVdKN2t5Mnd4TlV0aHQtTm53?oc=5" target="_blank">FDA Grants Breakthrough Therapy Designation to First-Line Daraxonrasib Plus Chemo in mPDAC</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPYkJ1bDVGaFU3dG1kclFSSlhqYjAySW1oZ25kelJTVWNJUWJ2UTl3MEd0Zmp2UV9xQm5EajJyb2VRZHR5R0tGXzlZc2FOWUlDR2hhRW1yOHMxRDBxMVNSd3E4NTFBV3hfOVEzTzVMbVF6c3l4TzdzY3oxbllXREptaGx2djI4SVFGdkdJVFktd1hyQzVOTWd1RENB?oc=5" target="_blank">Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug</a>&nbsp;&nbsp;<font color="#6f6f6f">The American Journal of Managed Care</font>
<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1oRExEblVEOHJjbGkwRExtVlZKVjlHam1vUTBhTkZuNm9yd0oxWVU3X2t5WEE0cXBVNzNtTVRZSFpOUko1blRhTllHRHNkcE42VzFta2J6bDZOU25fZHkxa1FWWFY?oc=5" target="_blank">FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncodaily</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPakp0aWczZFJ3dWV5SzBQRGpZdWY0dEhqdVFSTURTRHZONEd3bGN4YmNCSzFsRm01SjVYUlBuWF9FTTZuRnhEQW5CRGdkY1hHWHNHdWs4cjlvNGpnNURaVW1QTGlsZVM2YlNQS3JOWXMzbHJCZnFPT3FNdGtrTUoxSUp2YVV3MmxSUnZoV2VfTE5Rbmd2NGgwRVlHYVJUM051RjJUbXpQWi1vV0ZTS3pUaA?oc=5" target="_blank">FDA approves ‘game-changing’ pancreatic cancer drug</a>&nbsp;&nbsp;<font color="#6f6f6f">NBC News</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQVXBEcHpORGNpa1Bzc1RTOUJMVmxrdVBTcGxTVkYtZHhSdmVCc2ZEU2gzZV9oVGJUNi1yY2k5Wkw5VEF3TFBBNjdvZ05zM2lXOFZBQ0E1QUFidzY1TW5YelllanFHdS1LYTdMRGx2VEs3M3M0Z01IdlBWZ25iZzhKYUxnNVpBN01PeXlzeFBSMFFwMWxzQTFBMTNmajE2V050bnZmUQ?oc=5" target="_blank">FDA Approves Daraxonrasib, Validating RAS(ON) Tri-Complex Platform in Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharm International</font>
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQSmNBT2M1dDZJcnVEQjRWY3VpaE85SHRya1I4TTJkc2F0MFBySGpFNVdSSmhEa1IxWlY5dlRZamxTZTF1Zy1jVnJtX1lEOG1ZZnlUbk9pSjIxcHBac1pZWi01ODJrTXN1VFFJVHhvTjcxeGJsOHA1eGNWRkZCczlJdkE4Vmt6N3c5MGZ3aWF1WnZkbkR2TjJzbDNPaXFOdTJaZFRENGVqRExlak9RSldqNS1BYk11MzBpT0ZqNg?oc=5" target="_blank">FDA approves daraxonrasib for patients with metastatic pancreatic cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">News-Medical</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNS3lmSmcxaHJ4U0lPdXNTY3ZhQlN3RFN2a3FhR2NGMVZjOGs4TzhxRVY4bXZwSnc4MWhWS3c0bTZmb2RDRElpMi1wUVlkRnA0WVJKcWk0YThOc215OWpaY0JyNmF6NUtQc3dLZWRWYS1RZE5HZlhmMGwyMzlRWURHU1VPRHBKZFdmdlJCU201S2JWdjBSakNjZGNaUU9pTS1vZ1E?oc=5" target="_blank">Dr Reiss Binder on the FDA Approval of Daraxonrasib for Metastatic PDAC</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQdzRXbDRCMHhzaTJ4Qm1YQVJUSUkwYm5XbW5udWVkTFdUdkZyVHRzWkprSUdVUVpqVVBSeUY3VVlMNkJMMXdSU0x0LTYzenpVcEkwRHhXT3RQbWtIa0JMNnEyZU4ySXVkLTVQUnR6VFVXcllpQ2E3WHlpZ2FQMXhJUHBUSnJ2TEUxbWtoNkVCV2kxR0tvQ0Q5SEwwN0NUWFBW?oc=5" target="_blank">Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE11ZUlyMDlPeEtIbUNRYWIzcEJiQXVIaDZnWTVINC1vT0ZwcU5DOXlIMEpQUEo5d3FwMGRUcllubHNlQ2VJZDkwWWI0M1NyMG13YW80?oc=5" target="_blank">FDA Approves Daraxonrasib: Here is What Oncologists Have to Say</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncodaily</font>